GE Healthcare Embraces Solutions Role In Growing Regen Med Sector

GE Healthcare’s Life Sciences business continues to build its asset base in the cell and gene therapy sector, and after several strategic M&A deals in recent months is facing 2017 in a confident mood, according to Phil Vanek, cell therapy growth leader.